18.97.14.89
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Lupus Nephritis

Active disease, end-stage renal disease drive costs in lupus nephritis

Due to the high treatment burden and cost of patients with active disease and end-stage renal disease (ESRD) in Lupus nephritis (LN), achieving and maintaining low disease activity may help reduce medication use and overall healthcare costs, according to a study. In this retrospective analysis, total healthcare payer costs for...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-